Submitted for Publication: August 1, 2011; final revision received November 24, 2011; accepted December 2, 2011.
Author Contributions: Dr Schulz performed the statistical analyses for the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Drs Schulz, Bédard, and Newcorn had full access to all the data in the study.
Financial Disclosure: Dr Newcorn is a recipient of grants for research support from Eli Lilly & Co, Ortho-McNeil-Janssen, and Shire and is or has been an advisor/consultant for Alcobra, Biobehavioral Diagnostics, Eli Lilly & Co, Ortho-McNeil-Janssen, and Shire. Dr Newcorn is now a member of the advisory boards for NEOS, Otsuka, and Shionogi.
Funding/Support: This study was supported by research grants R01 MH070935 (Dr Newcorn), R01 MH070935-02S1 (Dr Newcorn), and K01 MH070892 (Dr Schulz) from the National Institutes of Health; by grant UL1RR029887 from the National Center for Research Resources, a component of the National Institutes of Health; and by research grant B4Z-US-X012 from Eli Lilly & Co (Dr Newcorn).
Role of the Sponsors: The funding sources had no role in the design or conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript. The contents of this article are solely the responsibility of the authors.
Additional Contributions: The baseline MRIs from a subset of the sample described in this article were used in a previous publication.33